281 related articles for article (PubMed ID: 33210551)
1. Human-derived osteoblast-like cells and pericyte-like cells induce distinct metastatic phenotypes in primary breast cancer cells.
Mayo V; Bowles AC; Wubker LE; Ortiz I; Cordoves AM; Cote RJ; Correa D; Agarwal A
Exp Biol Med (Maywood); 2021 Apr; 246(8):971-985. PubMed ID: 33210551
[TBL] [Abstract][Full Text] [Related]
2. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.
Ono M; Kosaka N; Tominaga N; Yoshioka Y; Takeshita F; Takahashi RU; Yoshida M; Tsuda H; Tamura K; Ochiya T
Sci Signal; 2014 Jul; 7(332):ra63. PubMed ID: 24985346
[TBL] [Abstract][Full Text] [Related]
3. Equine Mesenchymal Stromal Cells Retain a Pericyte-Like Phenotype.
Esteves CL; Sheldrake TA; Dawson L; Menghini T; Rink BE; Amilon K; Khan N; Péault B; Donadeu FX
Stem Cells Dev; 2017 Jul; 26(13):964-972. PubMed ID: 28376684
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells.
Molloy AP; Martin FT; Dwyer RM; Griffin TP; Murphy M; Barry FP; O'Brien T; Kerin MJ
Int J Cancer; 2009 Jan; 124(2):326-32. PubMed ID: 19003962
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells regulate melanoma cancer cells extravasation to bone and liver at their perivascular niche.
Correa D; Somoza RA; Lin P; Schiemann WP; Caplan AI
Int J Cancer; 2016 Jan; 138(2):417-27. PubMed ID: 26235173
[TBL] [Abstract][Full Text] [Related]
6. Not all MSCs can act as pericytes: functional in vitro assays to distinguish pericytes from other mesenchymal stem cells in angiogenesis.
Blocki A; Wang Y; Koch M; Peh P; Beyer S; Law P; Hui J; Raghunath M
Stem Cells Dev; 2013 Sep; 22(17):2347-55. PubMed ID: 23600480
[TBL] [Abstract][Full Text] [Related]
7. Pre-Osteoblasts Stimulate Migration of Breast Cancer Cells via the HGF/MET Pathway.
Vallet S; Bashari MH; Fan FJ; Malvestiti S; Schneeweiss A; Wuchter P; Jäger D; Podar K
PLoS One; 2016; 11(3):e0150507. PubMed ID: 26934743
[TBL] [Abstract][Full Text] [Related]
8. BMP9 regulates cross-talk between breast cancer cells and bone marrow-derived mesenchymal stem cells.
Wan S; Liu Y; Weng Y; Wang W; Ren W; Fei C; Chen Y; Zhang Z; Wang T; Wang J; Jiang Y; Zhou L; He T; Zhang Y
Cell Oncol (Dordr); 2014 Oct; 37(5):363-75. PubMed ID: 25209393
[TBL] [Abstract][Full Text] [Related]
9. Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment.
Yi D; Xiang W; Zhang Q; Cen Y; Su Q; Zhang F; Lu Y; Zhao H; Fu P
Cell Physiol Biochem; 2018; 46(1):279-290. PubMed ID: 29590646
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer bone metastases are attenuated in a Tgif1-deficient bone microenvironment.
Haider MT; Saito H; Zarrer J; Uzhunnumpuram K; Nagarajan S; Kari V; Horn-Glander M; Werner S; Hesse E; Taipaleenmäki H
Breast Cancer Res; 2020 Apr; 22(1):34. PubMed ID: 32272947
[TBL] [Abstract][Full Text] [Related]
11. N-cadherin mediates the migration of bone marrow-derived mesenchymal stem cells toward breast tumor cells.
Choi S; Yu J; Kim W; Park KS
Theranostics; 2021; 11(14):6786-6799. PubMed ID: 34093853
[No Abstract] [Full Text] [Related]
12. Osteoblasts are "educated" by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment.
Kolb AD; Shupp AB; Mukhopadhyay D; Marini FC; Bussard KM
Breast Cancer Res; 2019 Feb; 21(1):31. PubMed ID: 30813947
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition.
Pietrovito L; Leo A; Gori V; Lulli M; Parri M; Becherucci V; Piccini L; Bambi F; Taddei ML; Chiarugi P
Mol Oncol; 2018 May; 12(5):659-676. PubMed ID: 29517849
[TBL] [Abstract][Full Text] [Related]
14. TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines.
Shin SY; Nam JS; Lim Y; Lee YH
J Biol Chem; 2010 Oct; 285(40):30731-40. PubMed ID: 20650898
[TBL] [Abstract][Full Text] [Related]
15. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
Mendoza-Villanueva D; Zeef L; Shore P
Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors.
Zhang T; Lee YW; Rui YF; Cheng TY; Jiang XH; Li G
Stem Cell Res Ther; 2013 Jun; 4(3):70. PubMed ID: 23763837
[TBL] [Abstract][Full Text] [Related]
17. Decidualization modulates the mesenchymal stromal/stem cell and pericyte characteristics of human decidual stromal cells. Effects on antigen expression, chemotactic activity on monocytes and antitumoral activity.
Ruiz-Magaña MJ; Martinez-Aguilar R; Llorca T; Abadia-Molina AC; Ruiz-Ruiz C; Olivares EG
J Reprod Immunol; 2021 Jun; 145():103326. PubMed ID: 33965695
[TBL] [Abstract][Full Text] [Related]
18. The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro - evaluation towards understanding breast cancer cell bone metastasis.
Du WW; Fang L; Yang W; Sheng W; Zhang Y; Seth A; Yang BB; Yee AJ
BMC Cancer; 2012 Aug; 12():341. PubMed ID: 22862967
[TBL] [Abstract][Full Text] [Related]
19. An In Vitro Co-Culture Model of Bone Marrow Mesenchymal Stromal Cells and Peripheral Blood Mononuclear Cells Promotes the Differentiation of Myeloid Angiogenic Cells and Pericyte-Like Cells.
Uusitalo-Kylmälä L; Santo Mendes AC; Polari L; Joensuu K; Heino TJ
Stem Cells Dev; 2021 Mar; 30(6):309-324. PubMed ID: 33499756
[TBL] [Abstract][Full Text] [Related]
20. WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling.
Ma J; Li J; Wang Y; Chen W; Zheng P; Chen Y; Sun Z; Liu J; Zhou Y; Wang J; Liu S; Han X
Biomed Pharmacother; 2020 Jan; 121():109617. PubMed ID: 31810139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
